QuiVad

Home / United Kingdom / GW Pharmaceuticals PLC

GW Pharmaceuticals PLC

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 5.93% on August 1, 2014. The shaded band matches the twelve months of the first chart.

April 25, 2014 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on GW Pharmaceuticals PLC by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

470 disclosures on record for this share.
DateFund% of capitalEnd of publication
November 3, 2014D. E. Shaw & CO. LP0.79%
October 30, 2014D. E. Shaw & CO. LP0.89%
October 30, 2014PDT Partners, LLC0.58%
October 29, 2014D. E. Shaw & CO. LP0.97%
October 24, 2014PDT Partners, LLC0.66%
October 23, 2014D. E. Shaw & CO. LP1.05%
October 23, 2014PDT Partners, LLC0.72%
October 22, 2014D. E. Shaw & CO. LP1.11%
October 22, 2014PDT Partners, LLC0.82%
October 21, 2014D. E. Shaw & CO. LP1.09%
October 21, 2014Healthcor Management, L.P.1.02%
October 21, 2014PDT Partners, LLC0.76%
October 20, 2014D. E. Shaw & CO. LP1.14%
October 20, 2014PDT Partners, LLC0.63%
October 17, 2014D. E. Shaw & CO. LP1.21%
October 16, 2014D. E. Shaw & CO. LP1.37%
October 16, 2014Healthcor Management, L.P.0.94%
October 15, 2014D. E. Shaw & CO. LP1.47%
October 15, 2014PDT Partners, LLC0.55%
October 14, 2014D. E. Shaw & CO. LP1.56%
October 13, 2014Healthcor Management, L.P.0.79%
October 13, 2014PDT Partners, LLC0.62%
October 10, 2014Healthcor Management, L.P.1.23%
October 10, 2014PDT Partners, LLC0.56%
October 8, 2014D. E. Shaw & CO. LP1.67%
October 8, 2014Healthcor Management, L.P.1.32%
October 7, 2014D. E. Shaw & CO. LP1.50%
October 2, 2014Healthcor Management, L.P.1.79%
October 2, 2014PDT Partners, LLC0.61%
October 1, 2014D. E. Shaw & CO. LP1.47%
October 1, 2014PDT Partners, LLC0.56%
September 30, 2014PDT Partners, LLC0.62%
September 26, 2014PDT Partners, LLC0.59%
September 25, 2014D. E. Shaw & CO. LP1.27%
September 25, 2014PDT Partners, LLC0.63%
September 24, 2014PDT Partners, LLC0.59%
September 22, 2014D. E. Shaw & CO. LP1.14%
September 19, 2014D. E. Shaw & CO. LP1.01%
September 17, 2014D. E. Shaw & CO. LP0.95%
September 15, 2014D. E. Shaw & CO. LP1.02%
September 10, 2014PDT Partners, LLC0.66%
September 10, 2014Barclays Capital INC0.49%
September 9, 2014D. E. Shaw & CO. LP0.91%
September 9, 2014PDT Partners, LLC0.70%
September 8, 2014PDT Partners, LLC0.69%
September 5, 2014D. E. Shaw & CO. LP0.84%
September 5, 2014POINT72 Asset Management, L.P.0.16%
September 4, 2014D. E. Shaw & CO. LP0.79%
September 3, 2014POINT72 Asset Management, L.P.0.51%
September 2, 2014PDT Partners, LLC0.79%

Download 470 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GW Pharmaceuticals PLC, source FCA, data as at February 11, 2020, https://www.quivad.com/action/gw-pharmaceuticals-plc?page=7